Magazine article Clinical Psychiatry News

In Vivo Tau Imaging Confirms One Patient's AD Diagnosis

Magazine article Clinical Psychiatry News

In Vivo Tau Imaging Confirms One Patient's AD Diagnosis

Article excerpt

AT AAIC 2013

BOSTON -- The first investigational tau radioligand for PET imaging has identified pathologic tangles in the brain of a man who was confirmed postmortem to have Alzheimer's disease.

The patient who died was 1 of 12 participants in a study of the agent, [F-18]T808, and his imaging and neuropathologic results show that the agent binds exclusively to tau deposits, Hartmuth Kolb, Ph.D., said at a press conference at the Alzheimer's Association International Conference 2013.

The 85-year-old man died of a pulmonary embolism 2 weeks after his [F-18]T808 scan. His death was unrelated to his diagnosis or to the imaging agent, Dr. Kolb said. Avid Radiopharmaceuticals, the company developing the tracer, obtained the brain for autopsy.

The examination showed extensive tau tangles in exactly the same areas identified in a PET scan using [F-18]T808. Tau tangles show as red in the PET images; the warmer the shade, the more dense the tangles. "The results were quite striking," said Dr. Kolb, senior vice president of research at Avid. "The Braak stage was a 5 or 6, which corresponded with a Mini-Mental State Examination [MMSE] score of 15. On the scan, tau was all over the brain except for a sparing of the sensorimotor cortex, and that was exactly what we had found," in the postmortem exam.

The first human imaging cohort comprised nine patients with diagnosed Alzheimer's and three healthy control subjects. Investigators compared the in vivo PET images with immunohistochemistry and with staining from fluorescent tau ligand T557, which is used to identify the protein in postmortem exams.

In patients diagnosed with Alzheimer's, the [F-18]T808 scan showed strong positive correlations with the clinical exam in the temporal lobe, frontal lobe, parietal lobe, and hippocampus. The posterior cingulate gyrus and putamen were relatively spared, and the cerebellum was negative.

Patients with an MMSE score of 24 showed moderate tau deposition. Scans of three patients who had MMSE scores of 19, 14, and 3, respectively, showed a progressively denser tau concentration.

There was no significant tau accumulation in any of the three healthy control subjects.

There was one outlier--a patient with an MMSE score of 12 who showed only a very small amount of tau. Dr. Kolb said this patient was probably misdiagnosed as having Alzheimer's--a problem that continues to plague both clinicians and researchers.

"We don't have numbers of how many people are misdiagnosed every year, but we do know it's a big problem," Heather Snyder, Ph.D., director of medical and scientific operations for the Alzheimer's Association, said in an interview. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed


An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.